Palleon Pharmaceuticals
Jim Broderick is an accomplished biotech executive with more than 20 years of experience in the industry. He was Co-Founder and Chairman of Ra Pharmaceuticals (NASDAQ RARX, acquired by UCB), founding CEO of SetPoint Medical, and Co-Founder and Chairman of Promedior (acquired by Roche), while he was a partner at the venture capital firm Morgenthaler Ventures. Jim founded Palleon in collaboration with the venture capital firm SR One, where he served as an Entrepreneur-in-Residence. He earned a B.S. in mechanical engineering from MIT and an M.D. from UMass Medical School.
This person is not in any offices
Palleon Pharmaceuticals
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.